抗精神病药与COPD患者急性呼吸衰竭风险的相关性
该病例交叉研究分析台湾全民健保数据库,纳入2000至2011年因急性呼吸衰竭(ARF)需插管或机械通气的COPD患者。结果显示,抗精神病药使用与ARF风险增加相关(调整OR 1.66,95%CI 1.34-2.05),且呈剂量依赖性,高剂量风险更高。临床医生对COPD患者处方抗精神病药时应谨慎,尽量避免高剂量。
要点
- COPD患者使用抗精神病药与急性呼吸衰竭风险增加相关。
- 风险呈剂量依赖性,高剂量时风险显著升高。
- 临床应谨慎处方,尽可能避免高剂量使用。
核心结论
- 抗精神病药使用与COPD患者急性且剂量依赖的急性呼吸衰竭风险增加相关。
研究设计与样本
- 排除既往ARF、肺癌及心源性、创伤性或脓毒性ARF患者以分析特发性ARF。
主要发现
- 调整后ARF风险增加1.66倍(95%CI 1.34-2.05;P < .001),与抗精神病药类别和给药途径无关。
- 剂量依赖性风险:趋势检验调整OR 1.35(95%CI 1.19-1.52;P < .001),低日剂量风险1.52倍(95%CI 1.20-1.92;P < .001),高剂量风险3.74倍(95%CI 1.68-8.36;P = .001)。
- 病例-时间-对照分析调整OR 1.62(95%CI 1.16-2.27;P = .005),嵌套病例对照研究调整OR 2.16(95%CI 1.91-2.15;P < .001)。
临床怎么用
- 临床医生对COPD患者处方抗精神病药时应谨慎,尽可能避免高剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Acute respiratory failure (ARF) is a life-threatening event that has been linked in case reports to antipsychotic use, but this association lacks population-based evidence. Particular attention should be focused on patients with chronic obstructive pulmonary disease (COPD) regarding this drug safety concern because these patients are prone to ARF and are commonly treated with antipsychotics. OBJECTIVE: To determine whether the use of antipsychotics is associated with an increased risk of ARF in patients with COPD. DESIGN, SETTING, AND PARTICIPANTS: A population-based case-crossover study analyzing the Taiwan National Health Insurance Research Database was conducted of all patients with COPD, who were newly diagnosed with ARF in hospital or emergency care settings necessitating intubation or mechanical ventilation from January 1, 2000, to December 31, 2011. Patients with prior ARF, lung cancer, and cardiogenic, traumatic, or septic ARF were excluded to analyze idiopathic ARF. The pilot study was conducted from November 1 to December 31, 2013, and full data analysis was performed from October 15, 2015, to November 8, 2016. EXPOSURES: The use of antipsychotics was self-compared during days 1 to 14 (the risk period according to previous case reports) and days 75 to 88 (control period) preceding the ARF event or index date. The antipsychotic class, route of administration, and dose were also examined. MAIN OUTCOMES AND MEASURES: Risk of ARF. RESULTS: There were 5032 patients with ARF (mean [SD] age, 74.4 [9.9] years; 3533 males [70.2%]) among the 61 620 patients with COPD. Five hundred ninety patients with ARF (11.7%) filled at least 1 antipsychotic prescription during the case period compared with 443 (8.8%) during the control period, corresponding to a 1.66-fold (95% CI, 1.34-2.05; P < .001) adjusted increased risk of ARF regardless of antipsychotic class and administration route. A dose-dependent risk of ARF associated with antipsychotics was identified (test for trend, adjusted odds ratio, 1.35; 95% CI, 1.19-1.52; P < .001), which increased from a 1.52-fold risk for a low daily dose (95% CI, 1.20-1.92; P < .001) to a 3.74-fold risk for a high dose (95% CI, 1.68-8.36; P = .001). The increased risk persisted under a case-time-control analysis (adjusted odds ratio, 1.62; 95% CI, 1.16-2.27; P = .005) and nested case-control study (adjusted odds ratio, 2.16; 95% CI, 1.91-2.15; P < .001). CONCLUSIONS AND RELEVANCE: Antipsychotic use is associated with an acute and dose-dependent increased risk of ARF in patients with COPD. Clinicians should exercise caution when prescribing antipsychotics to patients with COPD and avoid high doses if possible.
引用
- Wang MT, Tsai CL, Lin CW, et al. Association Between Antipsychotic Agents and Risk of Acute Respiratory Failure in Patients With Chronic Obstructive Pulmonary Disease. JAMA Psychiatry. 2017. PMID: 28055066. doi:10.1001/jamapsychiatry.2016.3793
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。